Revenue slipped 5.2% but losses widened 31% and operating cash burn tripled

What changed

Revenue declined 5.2% to $9.3m from $9.8m, with gross margin contracting from approximately $6.9m to $5.9m (a gross margin percentage of 63.3% versus 70.2%, or a 690bps compression). PBT loss widened 30.9% to $(7.4)m and NPAT loss widened 30.5% to $(7.4)m. Operating cash outflow more than tripled to $(3.3)m from $(1.1)m, and pre-lease free cash flow deteriorated to $(4.2)m from $(1.8)m. Despite deeper losses, the balance sheet strengthened sharply: cash rose to $11.3m from $4.3m, total equity nearly doubled to $21.4m from $11.1m, and the company remains debt-free. The equity step-up of $10.4m substantially exceeds the full-year loss, pointing to a capital raise during the period.

What matters

• Losses accelerated on shrinking revenue. Gross profit fell roughly $1.0m while operating losses widened by $1.7m, showing cost base growth running ahead of revenue. This is the cleaner operating read because tax was effectively nil in both periods.
• Cash burn tripled and was second-half weighted. HY21 contributed only 33.4% of the full-year NPAT loss, meaning the second half ran at an implied $(4.9)m NPAT and $(2.0)m operating cash outflow — materially worse than H1. Receivable days deteriorated from 58 to 103, adding roughly $1.1m to debtors and explaining a meaningful portion of the operating cash gap.
• Balance sheet was recapitalised. Equity rose $10.4m, funding the loss and lifting cash to $11.3m. FX movements reduced cash by about $1.4m, which is material relative to the burn rate.

Expectations

The release states performance was "at analyst expectations" but provides no quantified FY22 guidance, forward-work balance, or medium-term target. HY21 represented 47.2% of full-year revenue, implying a modest second-half revenue lift to $4.9m — but NPAT and cash flow shapes both worsened in H2. Without a disclosed target or forward-work metric, the release supports a view that the business has funded runway but does not support any specific trajectory claim on when revenue growth or operating leverage returns.

Quality of result

The result is low quality on operating grounds. Revenue fell, gross margin compressed 690bps, and the divergence between the $(7.4)m NPAT and the $(3.3)m operating cash outflow is not flattering — the cash figure is softened by non-cash charges rather than working capital efficiency. Cash conversion deteriorated materially: receivable days rose 45 days, lifting operating working capital by $0.8m. The apparent balance sheet strength is equity-raise-driven rather than earned, and FX removed a further $1.4m of cash. Capex of $0.8m (9.1% of revenue, up from 7.9%) is modest but rising against a shrinking top line.

Unresolved

• What drove the revenue decline and 690bps gross margin compression given the stated positive mix shift toward recurring and transaction revenue?
• How much of the $10.4m equity increase was a primary raise, and at what price and dilution?
• Why did receivable days nearly double to 103, and is any of the $2.6m debtor balance at collection risk?
• What is the cash runway at the current H2 burn rate of roughly $2.0m per half, and is there a disclosed path to cash-flow breakeven?
• With >75% of revenue from the core segment, what is the underlying customer or geographic concentration?

This briefing cannot assess valuation, share count dynamics, segment-level economics, or forward order book, as none were disclosed in the supplied excerpts.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.